Relative efficacy of sildenafil compared to other treatment options for erectile dysfunction

Southern Medical Journal

Volumn 93, Issue 10, 2000, Pages 962-965

  Gauthier, Anthony ^b   Rutchik, Scott D ^a   Winters, J Christian ^b   Fuselier, Harold A ^b   Woo, Howard ^b   Prats, Lester J ^b   Bardot, Stephen ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; SILDENAFIL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; HUMAN; IMPOTENCE; MALE; MIDDLE AGED; NONPARAMETRIC TEST; ORGANIC IMPOTENCE; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; HUMANS; IMPOTENCE; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0034296731     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200093100-00003     Document Type: Article

References (15)

1. Goldstein I, Lue TF, Padma-Nathan H, et al: Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338:1397-1404
2. Hanash KA: Comparative results of goal oriented therapy for erectile dysfunction. J Urol 1997; 157:2135-2138
3. Burnett AL, Lowenstein CJ, Bredt DS, et al: Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257:401-403
4. Lue TF: Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. Campbell's Urology. Philadelphia, WB Saunders Co, Vol 2, 1998, pp 1157-1179
5. Boolell M, Allen MJ, Ballard S, et al: Sildenafil: an orally active type-5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8:47-52
6. Soderdahl DW, Thrasher JB, Hansberry KL: Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. Br J Urol 1997; 79:952-957
7. Turner LA, Althof SE, Levine SB, et al: Twelve-month com-parison of two treatments for erectile dysfunction: self-injection versus external vacuum devices. Urology 1992; 39:139-144
8. Hollander JB, Gonzalez J, Norman T: Patient satisfaction with pharmacologic erection program. Urology 1992; 39:439-441
9. Weiss JN, Badlani GH, Ravalli R, et al: Reasons for high drop-out rate with self-injection therapy for impotence. Int J Impot Res 1994; 6:171-174
10. Jarow JP, Burnett AL, Geringer AM: Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999; 162:722-725
11. Padma-Nathan H, Hellstrom WJG, Kaiser FE, et al: Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997; 336:1-7
12. Engel JD, McVary KT: Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. Urology 1998; 51:687-691
13. Porst H: Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil - a comparative study in 103 patients with erectile dysfunction. Int J Impot Res 1997; 9:187-192
14. Fulgham PR, Cochran JS, Denman JL, et al: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol 1998; 160:2041-2046
15. Zippe CD, Kedia AW, Kedia K, et al: Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology 1998; 52:963-966